Have a personal or library account? Click to login
In vitro cytogenotoxic evaluation of sertraline Cover

References

  1. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing.10.1176/appi.books.9780890425596
  2. Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, Gonçalves CA and Kapczinski F. (2007). DNA damage in bipolar disorder. Psychiatry Res153: 27–32.10.1016/j.psychres.2006.03.025
  3. Battal D, Aktas A, Sungur MA, Kadıoğlu E, Eker ED, Sahin NO and Saygı S. (2013). In vivo genotoxicity assessment of sertraline by using alkaline comet assay and the cytokinesis-block micronucleus assay. Basic Clin Pharmacol Toxicol113: 339–46.10.1111/bcpt.12095
  4. Battal D, Yalin S, Eker ED, Aktas A, Sahin NO, Cebo M and Berkoz M. (2014). Possible role of selective serotonin reuptake inhibitor sertraline on oxidative stress responses. Eur Rev Med Pharmacol Sci18: 477–484.
  5. Bonassi S, El-Zein R, Bolognesi C and Fenech M. (2011). Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies. Mutagenesis26: 93–100.10.1093/mutage/geq075
  6. Bozkurt G, Abay E, Ates I, Karabogaz G, Ture M, Savran FO, Palanduz S, Temocin K and Algunes C. (2004). Clastogenicity of selective serotonin-reuptake inhibitors. Mutat Res558: 137–44.10.1016/j.mrgentox.2003.11.005
  7. Brambilla G, Mattioli F and Martelli A. (2009). Genotoxic and carcinogenic effects of antipsychotics and antidepressants. Toxicology261: 77–88.10.1016/j.tox.2009.04.056
  8. Celada P, Puig MV, Amargós-Bosch M, Adell A and Artigas F. (2004). The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci29: 252.
  9. Chen S, Xuan J, Wan L, Lin H, Couch L, Mei N, Dobrovolsky VN and Guo L. (2013). Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol Sci137: 404–415.10.1093/toxsci/kft254
  10. Chung CP, Schmidt D, Stein CM, Morrow JD and Salomon RM. (2013). Increased oxidative stress in patients with depression and its relationship to treatment. Psychiatry Res206: 213–216.10.1016/j.psychres.2012.10.018
  11. Daniel WA, Wójcikowski J and Pałucha A. (2001). Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping. Br J Pharmacol134: 807–814.10.1038/sj.bjp.0704319
  12. Dielschneider RF, Henson ES and Gibson SB. (2017). Lysosomes as oxidative targets for cancer therapy. Oxid Med Cell Longev2017: 3749157.10.1155/2017/3749157
  13. Erel O. (2004). A novel automated direct measurement method for total anti-oxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem37: 277–85.10.1016/j.clinbiochem.2003.11.015
  14. Fenech M. (2007). Cytokinesis-block micronucleus cytome assay. Nature Protocols2: 1084–1104.10.1038/nprot.2007.77
  15. Fenech M, Holland N, Zeiger E, Chang WP, Burgaz S, Thomas P, Bolognesi C, Knasmueller S, Kirsch-Volders M and Bonassi S. (2011). The HUMN and HUMNxL international collaboration projects on human micronucleus as-says in lymphocytes and buccal cells–past, present and future. Mutagenesis26: 239–245.10.1093/mutage/geq051
  16. Fernandez LL, Montes-Bayon M, Gonzalez EB, Sierra LM, Sanz-Medel A and Bettmer J. (2011). Initial studies on quantitative DNA induced oxidation by gel electrophoresis (GE)-ICP-MS. J Anal Atom Spectrom26: 195–200.10.1039/C0JA00163E
  17. Franco CC, Castro-Prado J, Rosada LJ, Sant'Anna JR and Castro-Prado MA. (2010). Mitotic recombination: a genotoxic effect of the antidepressant citalopram in Aspergillus nidulans. Exp Biol Med235: 1257–1262.10.1258/ebm.2010.010159
  18. Gürbüzel M, Oral E, Kızılet H, Halıcı Z and Gulec M. (2012). Genotoxic evaluation of selective serotonin-reuptake inhibitors by use of the somatic mutation and recombination test in Drosophila melanogaster. Mutat Res748: 17–20.10.1016/j.mrgentox.2012.06.004
  19. Halliwell B and Gutteridge JMC. (2000). Free radicals in biology and medicine. Third ed. Oxford: Oxford Science Publications; p. 617–24.
  20. Harma M, Harma M and Erel O. (2003). Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly133: 563–536.10.4414/smw.2003.10397
  21. Jeong YC and Swenberg JA. (2004). Secondary DNA damage from reactive oxygen species. Cancer Res64: 175.
  22. Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M Jr, Kirchner S, Lorge E, Morita T, Norppa H, Surralles J, Vanhauwaert A and Wakata A. (2003). Report from the in vitro micronucleus assay working group. Mutat Res540: 153–163.10.1016/j.mrgentox.2003.07.005
  23. Kösecik M, Erel O, Sevinc E and Selek S. (2005). Increased oxidative stress in children exposed to passive smoking. Int J Cardiol100: 61–4.10.1016/j.ijcard.2004.05.069
  24. Lacaze E, Pédelucq J, Fortier M, Brousseau P, Auffret M, Budzinski H and Fournier M. (2015). Genotoxic and immunotoxic potential effects of selected psychotropic drugs and antibiotics on blue mussel (Mytilus edulis) hemocytes. Environ Pollut202: 177–186.10.1016/j.envpol.2015.03.025
  25. Li Y, Couch L, Higuchi M, Fang JL and Guo L. (2012). Mitochondrial dysfunction induced by sertraline, an antidepressant agent. Toxicol Sci127: 582–591.10.1093/toxsci/kfs100
  26. Lin CJ, Robert F, Sukarieh R, Michnick S and Pelletier J. (2010). The antidepressant sertraline inhibits translation initiation by curtailing mammalian target of rapamycin signaling. Cancer Res70: 3199–3208.10.1158/0008-5472.CAN-09-4072
  27. MacQueen G, Born L and Steiner M. (2001). The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders. CNS Drug Rev7: 1–24.10.1111/j.1527-3458.2001.tb00188.x
  28. Parks A and Marceau F. (2016). Lysosomotropic cationic drugs induce cyto-static and cytotoxic effects: Role of liposolubility and autophagic flux and antagonism by cholesterol ablation. Toxicol Appl Pharmacol305: 55–65.10.1016/j.taap.2016.06.006
  29. Rang HP, Dale MM and Ritter JM. (2001). Pharmacology, 4th edition. Edinburgh, UK Harcourt Publishers Ltd, 2001165–176.
  30. Rothfuss A, Schutz P, Bochum S, Volm T, Eberhardt E, Kreirenberg R, Vogel W and Speit G. (2000). Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res60: 390–394.
  31. Schildkraut JJ. (1967). The catecholamine hypothesis of affective disorders. A review of supporting evidence. Int J Geriatr Psychiatry4: 203–17.
  32. Seligman MEP. (2006). Learned optimism. Vintage Books. New York. 319p.
  33. Simandan T, Sun J and Dix TA. (1998). Oxidation of DNA bases, deoxyribonucleosides and homopolymers by peroxyl radicals. Biochem J335: 233–240.10.1042/bj3350233
  34. Snyder RD, Ewing D and Hendry LB. (2006). DNA intercalative potential of marketed drugs testing positive in in vitro cytogenetics assays. Mutat Res609: 47–59.10.1016/j.mrgentox.2006.06.001
  35. Suksomtip M and Pongsamart S. (2008). Protective effect against oxidation of human low-density lipoprotein and plasmid DNA strand scission of Tamarind seed coat extract in vitro. LWT – Food Sci Technol41: 2002–2007.10.1016/j.lwt.2008.01.018
  36. Taler M, Gil-Ad I, Lomnitski L, Korov I, Baharav E, Bar M, Zolokov A and Weizman, A. (2007). Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol17: 774–780.10.1016/j.euroneuro.2007.03.010
  37. Timocin T, Husunet MT, Valipour E, Norizadeh Tazehkand, M, Celik R, Topaktas M and Ila H B. (2017). In vitro cytogenetic evaluation of the particular combination of flurbiprofen and roxithromycin. Drug Chem Toxicol40: 326–332.10.1080/01480545.2016.1223097
  38. Wiedemann PM and Schutz H. (2008). The role of evidence in risk characterization: making sense of conflicting data. Weinheim: Wiley-VCH10.1002/9783527622351
  39. Young IS and Woodside JV. (2001). Antioxidants in health and disease. J Clin Pathol54: 176–86.10.1136/jcp.54.3.176
  40. Yumru M, Savas HA, Kalenderoglu A, Bulut M, Celik H and Erel O. (2009). Oxidative imbalance in bipolar disorder subtypes: a comparative study. Prog Neuropsychopharmacol Biol Psychiatry33: 1070–4.10.1016/j.pnpbp.2009.06.005
DOI: https://doi.org/10.2478/intox-2018-0015 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 181 - 188
Submitted on: Nov 3, 2017
Accepted on: May 15, 2018
Published on: Oct 18, 2019
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Erman Salih Istifli, Rima Çelik, Mehmet Tahir Hüsunet, Nesrin Çetinel, Osman Demirhan, Hasan Basri Ila, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.